|
|
345 Oyster Point Blvd.
South San Francisco, CA 94080-1913 USA
phone:(650) 635-1100
fax:(650) 635-1111
|
|
| Symbol |
MGRM |
| Exchange |
NASDAQ |
| Founded |
0 |
| Employees |
|
|
|
| www.MonogramBio.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Formerly ViroLogic, Mongram develops, markets and sells products to guide and improve treatment of viral diseases. |
|
| Management |
| William D. Young, Chairman of the Board and Chief Executive Officer; Michael P. Bates, MD, Vice President, Clinical Research; Michael J. Dunn, Chief Business Officer; Timothy G. Henn, Vice President, Finance; Kathy L. Hibbs, Senior Vice President, General Counsel; Kenneth N. Hitchner, Vice President, Pharmaceutical Collaborations; Alfred G. Merriweather, Senior Vice President, Chief Financial Officer; Gordon Parry, PhD, Vice President of Research and Development, Oncology; Christos J. Petropoulos, PhD, Vice President, Research and Development, Virology and Chief Scientific Officer; Michael G. Vicari, Vice President, Sales; William J. Welch, Senior Vice President and Chief Commercial Officer; Jeannette M. Whitcomb, PhD, Vice President, Operations; Patricia Wray, Vice President, Human Resources |
| |
|
|
|
|
|
|
|
| Keywords |
| HIV/AIDS, hepatitis B, hepatitis C, clinical studies, research, viral disease, drug resistence, HIVAIDS, personalized |
|
|
|
| Description |
|
Formerly ViroLogic.
Mongram develops, markets and sells products to guide and improve treatment of viral diseases. The company developed a practical way of directly measuring the impact of genetic mutations on drug resistance and using this information to guide therapy. |
|
| Products / Services |
PhenoSense HIV, GeneSeq HIV, PhenoSense GT, Replication Capacity HIV, PhenoScreen, PhenoSense HIV Entry, GeneSeq HIV Entry, PhenoSense HIV Vaccine Entry and GeneSeq HBV.
|
|
| Technology / Differentiation |
| PhenoSense, their proprietary technology, is used to test drug resistance in viruses that cause serious diseases, such as HIV/AIDS, hepatitis B and hepatitis C. |
|
| Market / Customers |
Monogram's products are used by physicians for selecting optimal treatments for their HIV patients and by industry, academia and government for clinical studies, drug screening and characterization and basic research.
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
